Louis Perri, MD
Plastic and Reconstructive Surgery · Sewell, NJNPI 1225125255
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 354 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations.
Across 354 payments — averaging $15.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$639
- Mayne Pharma Commercial LLC$600
- LEO Pharma Inc.$566
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$434
- Regeneron Healthcare Solutions, Inc.$430
- Johnson & Johnson$383
- plus $2K from 29 others
What the payments were for
- Food & beverage$5,39498%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 6 | $639 |
| Mayne Pharma Commercial LLC | 70 | $600 |
| LEO Pharma Inc. | 39 | $566 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 19 | $434 |
| Regeneron Healthcare Solutions, Inc. | 21 | $430 |
| Johnson & Johnson | 25 | $383 |
| Novartis | 31 | $374 |
| Sanofi | 17 | $260 |
| Pfizer | 14 | $223 |
| Galderma Laboratories, L.p. | 13 | $183 |
| AbbVie(2 entities) | 11 | $182 |
| Bristol Myers Squibb | 17 | $155 |
| Amgen | 8 | $122 |
| UCB, Inc. | 6 | $103 |
| Lilly USA, LLC | 6 | $93 |
| E.r. Squibb & Sons, L.L.C. | 5 | $81 |
| EPI Health, LLC | 5 | $66 |
| VYNE Pharmaceuticals Inc. | 5 | $63 |
| Incyte Corporation | 4 | $59 |
| Verrica Pharmaceuticals Inc. | 3 | $57 |
| Genentech USA, Inc. | 4 | $53 |
| Dermira, Inc. | 3 | $43 |
| Kowa Pharmaceuticals America, Inc. | 3 | $41 |
| Mission Pharmacal Company | 3 | $37 |
| Sun Pharmaceutical Industries Inc. | 2 | $37 |
| Revance Therapeutics, Inc. | 2 | $36 |
| Organon | 2 | $26 |
| Journey Medical Corporation | 2 | $26 |
| Encore Dermatology Inc. | 2 | $24 |
| Sandoz | 1 | $22 |
| Triad Life Sciences Inc. | 1 | $19 |
| Fresenius Kabi USA, LLC | 1 | $16 |
| Almirall LLC | 1 | $14 |
| Glenmark Therapeutics Inc. | 1 | $14 |
| Aclaris Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,494 in reported general payments places this provider in the 80th percentile of 93 plastic and reconstructive surgery providers in New Jersey.
See all plastic and reconstructive surgery providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Dipropionate | 63 | $2,333 |
| Ivermectin | 14 | $2,299 |
| Metronidazole | 18 | $1,854 |
| Mupirocin | 249 | $1,690 |
| Clobetasol Propionate | 56 | $1,553 |
| Cefadroxil | 292 | $1,396 |
| Fluocinonide | 33 | $1,257 |
| Fluticasone Propionate | 40 | $848 |
| Fluorouracil | 14 | $833 |
| Ketoconazole | 44 | $742 |
| Doxycycline Hyclate | 17 | $730 |
| Econazole Nitrate | 11 | $314 |
| Clindamycin Phosphate | 15 | $272 |
| Hydroxyzine Hcl | 28 | $232 |
| ErythromycinErythromycin Base | 13 | $157 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Sewell
- Sara ColeCherry Hill$63K
- Edward LeeRahway$50K
- Eric ChangFlorham Park$41K
- Colin FaileyFlorham Park$40K
- Steve FallekEnglewood$34K
- Barry DibernardoMontclair$31K
- Michael NagyManasquan$27K
- John TaylorRed Bank$18K
- Francisco ColonFlorham Park$16K
- Peter AndrawesRed Bank$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.